Contraception and pregnancy counselling in rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 26, Issue 3, 2014, Pages 302-307

  Østensen, Monika ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

adjustment of therapy; contraception; counselling; pregnancy outcome; rheumatoid arthritis

Indexed keywords

CHEMICAL TERATOGEN; CODEINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ESTROGEN; LA ANTIGEN; LEVONORGESTREL; METHOTREXATE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RHEUMATOID FACTOR; RO ANTIBODY; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

BIRTH CONTROL; BREAST FEEDING; CESAREAN SECTION; CONTRACEPTION; DISEASE ACTIVITY; DISEASE COURSE; DRUG USE; FAMILY PLANNING; FEMALE FERTILITY; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; MATERNAL AGE; META ANALYSIS (TOPIC); MONOTHERAPY; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REMISSION; REPRODUCTION; REPRODUCTIVE HEALTH; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMALL FOR DATE INFANT; UNPLANNED PREGNANCY; VAGINAL DELIVERY; ARTHRITIS, RHEUMATOID; COUNSELING; FEMALE; MATERNAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CONTRACEPTION; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, UNPLANNED;

EID: 84897564701     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000044     Document Type: Review

References (35)

1. Eriksson JK, Neovius M, Ernestam S, et al. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res 2013; 65:870-878.
2. Wallenius M, Skomsvoll JF, Irgens LM, et al. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis 2010; 69:332-336.
3. Forger F, Vallbracht I, Helmke K, et al. Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly 2012; 142:w13644.
4. Lstensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 2007; 34:1266-1269.
5. Martínez Lopez JA, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol 2009; 27:678-684.
6. Farr SL, Folger SG, Paulen ME, Curtis KM. Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review. Contraception 2010; 82:64-71.
7. Østensen M. Contraception counselling in SLE-an often forgotten duty? Nat Rev Rheumatol 2011; 7:315-316.
8. Spector TD, Hochberg MC. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis. Brit J Rheumatol 1989; 28 (Suppl 1):11-12.
9. Pladevall-Vila M, Delclos GL, Varas C, et al. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 1996; 144:1-14.
10. Camacho EM, Lunt M, Farragher TM, et al. The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 2011; 63:2183-2191.
11. Stidham Hall K, Moreau C, Trussell J, Barber J. Young women's consistency of contraceptive use: does depression or stress matter? Contraception 2013; 88:641-649.
12. de Man YA, Bakker-Jonges LE, Goorbergh CM, et al. Women with rheumatoid arthritis negative for anticyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2010; 69:420-423.
13. de Man YA, Dolhain RJ, van de Geijn FE, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008; 59:1241-1248.
14. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999; 42:1219-1227.
15. Reed SD, Vollan TA, Svec M.A. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006; 10:361-366.
16. Lin HC, Chen SF, Lin HC, Chen YH. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010; 69:715-717.
17. Nørgaard M, Larsson H, Pedersen L, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 2010; 268:329-337.
18. Barnabe C, Faris PD, Quan H. Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011; 2011:345727.
19. Wallenius M, Skomsvoll JF, Irgens LM, et al. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 2011; 63:1534-1542.
20. Bowden AP, Barrett JH, Fallow W, Silman AJ. Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol 2001; 28:355-359.
21. de Man YA, Hazes JM, van der Heide H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60:3196-3206.
22. Østensen M, Fuhrer L, Mathieu R, et al. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 2004; 63:1212-1217.
23. Barrett JH, Brennan P, Fiddler M, Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000; 43:1010-1015.
24. Khalil A, Syngelaki A, Maiz N, et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2013; 42:634-643.
25. Cavazzana I, Franceschini F, Quinzanini M, et al. Anti-Ro/SSA antibodies in rheumatoid arthritis. Clin Exp Rheumatol 2006; 24:59-64.
26. Olech E, Merrill JT. The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr Rheumatol Rep 2006; 8:100-108.
27. Rein AJJT, Mevorach D, Perles Z, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation 2009; 119:1867-1872.
28. Wallenius M, Skomsvoll JF, Irgens LM, et al. Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 2011; 50:1162-1167.
29. Clowse M, Chakravarty E, Costenbader K, et al. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 2012; 64:668-674.
30. Jawaheer D, Zhu JL, Nohr EA, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011; 63:1517-1521.
31. Vinet E, Kuriya B, Pineau CA, et al. Induced abortions in women with rheumatoid arthritis receiving methotrexate. Arthritis Care Res 2013; 65: 1365-1369.
32. Hämeen-Anttila K, Jyrkkä J, Enlund H, et al. Medicines information needs during pregnancy: a multinational comparison. BMJ Open 2013; 3:e002594. doi:10.1136/bmjopen-2013-002594.
33. Czeizel AE, Dudás I, Vereczkey A, Bánhidy F. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients 2013; 5:4760-4775.
34. Burdan F, Starosławska E, Szumiło J. Prenatal tolerability of acetaminophen and other over-the-counter nonselective cyclooxygenase inhibitors. Pharmacol Rep 2012; 64:521-527.
35. Østensen M, Förger F. How safe are antirheumatic drugs in pregnancy? Cur Opinion Pharmacol 2013; 13:470-475.